TrialBMC infectious diseases2024

RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trial.

Aurelio Bonavia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.